{
    "eid": "2-s2.0-85164320262",
    "title": "Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Na\u00efve People With Human Immunodeficiency Virus",
    "cover-date": "2023-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "hepatitis B",
        "HepB-CpG",
        "Heplisav-B",
        "HIV",
        "vaccine"
    ],
    "authors": [
        "Kristen M. Marks",
        "Minhee Kang",
        "Triin Umbleja",
        "Anchalee Avihingsanon",
        "Patcharaphan Sugandhavesa",
        "Andrea L. Cox",
        "Karen Vigil",
        "Hugo Perazzo",
        "Jennifer C. Price",
        "Leolin Katsidzira",
        "Christina Vernon",
        "Beverly Alston-Smith",
        "Kenneth E. Sherman"
    ],
    "citedby-count": 0,
    "ref-count": 9,
    "ref-list": [
        "Immune response to hepatitis B virus vaccine among people living with HIV: a meta-analysis",
        "Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18\u201355 years of age",
        "Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40\u201370 years of age",
        "Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a Toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults",
        "Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease",
        "Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220",
        "Long-term response rates of successful hepatitis B vaccination in HIV-infected patients",
        "Serological response with heplisav-B(R) in prior hepatitis B vaccine non-responders living with HIV",
        "Brief report: heplisav-B seroprotection in people with HIV: a single-center experience"
    ],
    "affiliation": [
        {
            "affiliation-city": "Harare",
            "@id": "60066846",
            "affilname": "Godfrey Huggins School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60066846",
            "affiliation-country": "Zimbabwe"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60031970",
            "affilname": "UCSF School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031970",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rio de Janeiro",
            "@id": "60023997",
            "affilname": "Instituto Nacional de Infectologia Evandro Chagas (INI)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023997",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60021568",
            "affilname": "University of Texas Medical School at Houston",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021568",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cincinnati",
            "@id": "60017412",
            "affilname": "University of Cincinnati College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017412",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bethesda",
            "@id": "60017336",
            "affilname": "National Institute of Allergy and Infectious Diseases (NIAID)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017336",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "@id": "60007997",
            "affilname": "Weill Cornell Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60005478",
            "affilname": "Center for Biostatistics in AIDS Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005478",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60005248",
            "affilname": "Johns Hopkins University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005248",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Silver Spring",
            "@id": "127893273",
            "affilname": "DLH Corporation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127893273",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Al069432-17 Instituto de Pesquisa Clinica Evandro Chagas",
        "CMU HIV Treatment",
        "Cecilia Rivas Alfaro\u2014University of California",
        "Chiang Mai University HIV Treatment",
        "Columbia Physicians & Surgeons",
        "DLSHSI-AKMRC",
        "Dynavax Technologies",
        "Eli Burnham",
        "FNP-BC",
        "Harbor University of California, Los Angeles Center CRS",
        "IPEC",
        "Instituto de Pesquisa Clinica Evandro Chagas",
        "Matthew Planchon\u2014Massachusetts General Hospital",
        "New Jersey Medical School Clinical Research Center CRS",
        "Salle Health Science Institute Angelo King Medical Research Center",
        "TRC-ARC",
        "UM1AI69399 New Jersey Medical School Clinical Research Center CRS",
        "UM1AI69452 Megan Dieterich",
        "UM1AI69453 Joint Clinical Research Centre",
        "UM1AI69481 Teresa Spitz",
        "UM1AI69511 Alabama",
        "University of Colorado Hospital",
        "University of Rochester Adult HIV Therapeutic Strategies Network CRS",
        "University of the Witwatersrand Helen Joseph",
        "Vanderbilt Therapeutics",
        "Weill Cornell Chelsea CRS",
        "Weill Cornell Uptown CRS",
        "NIH",
        "National Institute of Allergy and Infectious Diseases",
        "University of Washington",
        "Johns Hopkins University",
        "University of Pittsburgh",
        "ACTG",
        "CRS",
        "JCRC",
        "Hanoi Medical University",
        "WITS",
        "HMU"
    ]
}